As prostate cancer has a long aetiology, it is important that men from this New Zealand selenium supplementation study be prospectively monitored for any future prostate cancer recordings, and to understand the interactive genetic, nutrient and serum PSA measures in such prostate cancer outcomes. This evidence concerns the gene KLK3 and Familial prostate cancer.